-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WPFxyKscun05i0Dy39jG4O+RtAhmANyADW4EDZnZBUzIPkPQepOSQKak4jCSTT7Q ru4khbXBDE9EBHKFcdYdvA== 0001441848-10-000019.txt : 20100423 0001441848-10-000019.hdr.sgml : 20100423 20100423125659 ACCESSION NUMBER: 0001441848-10-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100421 FILED AS OF DATE: 20100423 DATE AS OF CHANGE: 20100423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hora Maninder CENTRAL INDEX KEY: 0001443159 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34154 FILM NUMBER: 10766649 MAIL ADDRESS: STREET 1: PDL BIOPHARMA, INC. STREET 2: 1400 SEAPORT BOULEVARD CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FACET BIOTECH CORP CENTRAL INDEX KEY: 0001441848 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263070657 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1500 SEAPORT BLVD. CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-454-1000 MAIL ADDRESS: STREET 1: 1500 SEAPORT BLVD. CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Biotech Spinco, Inc. DATE OF NAME CHANGE: 20080804 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2010-04-21 0 0001441848 FACET BIOTECH CORP FACT 0001443159 Hora Maninder C/O FACET BIOTECH CORPORATION 1500 SEAPORT BOULEVARD REDWOOD CITY CA 94063 0 1 0 0 VP, Prod Ops. & Quality Common Stock 2010-04-21 4 D 0 13803 27 D 0 D Stock Option (Right to Buy) 6.17 2010-04-21 4 D 0 32000 27 D 2016-01-23 Common Stock 32000 0 D Stock Option (Right to Buy) 9.55 2010-04-21 4 D 0 16856 27 D 2016-04-02 Common Stock 16856 0 D Stock Option (Right to Buy) 9.95 2010-04-21 4 D 0 16000 27 D 2016-08-06 Common Stock 16000 0 D These shares were canceled and exchanged for a cash payment of $372,681.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. Includes shares not previously reported that were acquired under a Section 423 employee stock purchase plan. This stock option was canceled and exchanged for a cash payment of $666,560.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. The cash payment made with respect to this stock option equals the product of (x) the number of option shares canceled multiplied by (y) the difference between the merger consideration ($27 per share) and the exercise price for this stock option. This stock option was canceled and exchanged for a cash payment of $294,137.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. The cash payment made with respect to this stock option equals the product of (x) the number of option shares canceled multiplied by (y) the difference between the merger consideration ($27 per share) and the exercise price for this stock option. This stock option was canceled and exchanged for a cash payment of $272,800.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. The cash payment made with respect to this stock option equals the product of (x) the number of option shares canceled multiplied by (y) the difference between the merger consideration ($27 per share) and the exercise price for this stock option. /s/ Maninder Hora 2010-04-21 -----END PRIVACY-ENHANCED MESSAGE-----